OpenVSafe by OpenVAERS
Search V-safe

KZ3-36763-50366

2 vaccinations 8 coded responses 22 check-ins 8 free-text entries 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
774 / TX
Registered
2021-03-31
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-31
    Registered in v-safe
  2. 2021-03-31
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-31
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  4. 2021-04-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Redness, Itching · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-04-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Itching · Headache, Muscle or body aches
    Adult check-in
  6. 2021-04-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  8. 2021-04-07
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-14
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-04-30
    Dose 2 — Pfizer-BioNTech
  11. 2021-04-30
    Survey response — day 0, dose 2
    MedDRA: Headache, Hypoaesthesia, Injection site hypoaesthesia — Feeling: Good · Site: Pain · Fever · Headache, Diarrhea
    Free text: Numbness on right side of head (injection site on right arm, headache on right side of head)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-05-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Insomnia — Feeling: Good · Site: Pain, Itching · Fever · Chills, Fatigue or tiredness, Diarrhea
    Free text: Insomnia
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-05-02
    Survey response — days 1–6 daily, dose 2
    MedDRA: Insomnia — Feeling: Good · Site: Pain · Fatigue or tiredness, Diarrhea
    Free text: Insomnia
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-05-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  15. 2021-05-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fever · None
    Adult check-in
  16. 2021-05-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-05-07
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-05-14
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-05-21
    Survey response — day 21, dose 2
    MedDRA: Cough, Headache, Nasal congestion, Oropharyngeal pain, Sinusitis — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Viral sinus infection: sore throat, nasal congestion, cough, headache
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-05-21
    Report sent to call center — day 21, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  21. 2021-05-28
    Survey response — day 28, dose 2
    MedDRA: Cough, Nasal congestion, Oropharyngeal pain, Rhinorrhoea, Sneezing — Feeling: Good · Be unable to do your normal daily activities
    Free text: Cough, nasal congestion, runny nose, sneeze, sore throat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-06-04
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-06-11
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-07-30
    Survey response — 3 months, dose 2
    MedDRA: Migraine — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Migraine
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  25. 2021-10-30
    Survey response — 6 months, dose 2
    MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school
    Free text: Common cold
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-05-01
    Survey response — 12 months, dose 2
    MedDRA: Pre-existing disease, Sinusitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Sinus infection and allergy to pollens
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-05-01
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  28. 2022-05-03

Vaccinations

DoseDateManufacturerCo-administered
12021-03-31Pfizer-BioNTech
22021-04-30Pfizer-BioNTech

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 8 — day 0, dose 2

2021-04-30

Systemic reaction (other): Numbness on right side of head (injection site on right arm, headache on right side of head)

Release 8 — days 1–6 daily, dose 2

2021-05-01

Systemic reaction (other): Insomnia

2021-05-02

Systemic reaction (other): Insomnia

Release 8 — day 21, dose 2

2021-05-21

Symptoms: Viral sinus infection: sore throat, nasal congestion, cough, headache

Release 8 — day 28, dose 2

2021-05-28

Symptoms: Cough, nasal congestion, runny nose, sneeze, sore throat

Release 9 — 3 months, dose 2

2021-07-30

Symptoms: Migraine

Release 10 — 6 months, dose 2

2021-10-30

Symptoms: Common cold

Release 11 — 12 months, dose 2

2022-05-01

Symptoms: Sinus infection and allergy to pollens

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDMigraine ✓ · ✓
SDNasal congestion ✓ ✓ ✓
SDNasopharyngitis · · ✓
SDOropharyngeal pain ✓ ✓ ✓
SDPre-existing disease · · ✓
SDRhinorrhoea ✓ ✓ ✓
SDSinusitis ✓ ✓ ✓
SDSneezing ✓ ✓ ✓
SROHeadache ✓ ✓ ✓
SROHypoaesthesia ✓ ✓ ✓
SROInjection site hypoaesthesia ✓ ✓ ✓
SROInsomnia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release